Related references
Note: Only part of the references are listed.Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
lncRNAs and microRNAs with a role in cancer development
Julia Liz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation (vol 17, pg 648, 2016)
Ivan Bahena-Ocampo et al.
EMBO REPORTS (2016)
Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions
Stacey K. Mardekian et al.
HUMAN PATHOLOGY (2016)
Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
Stephanie Zdanov et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Direct Conversion of Human Myoblasts into Brown-Like Adipocytes by Engineered Super-Active PPARγ
Yanbei Zhu et al.
OBESITY (2015)
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Insaf Fkih M'hamed et al.
CELLULAR ONCOLOGY (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer
Xu Han et al.
CANCER GENE THERAPY (2014)
αvβ6 Expression in Myoepithelial Cells: A Novel Marker for Predicting DCIS Progression with Therapeutic Potential
Michael D. Allen et al.
CANCER RESEARCH (2014)
Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
Michael D. Allen et al.
CLINICAL CANCER RESEARCH (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
The microRNA networks of TGFβ signaling in cancer
V. P. Sivadas et al.
TUMOR BIOLOGY (2014)
Regulation of miRNA biogenesis as an integrated component of growth factor signaling
Matthew T. Blahna et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer
Yoomi Choi et al.
HUMAN PATHOLOGY (2013)
Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
Catherine F. Cowell et al.
MOLECULAR ONCOLOGY (2013)
FIP200 inhibits β-catenin-mediated transcription by promoting APC-independent β-catenin ubiquitination
J. D. Choi et al.
ONCOGENE (2013)
Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis
M. V. Yigit et al.
ONCOGENE (2013)
miR-199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced Lung Fibroblast Activation by Targeting Caveolin-1
Christian Lacks Lino Cardenas et al.
PLOS GENETICS (2013)
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J. Esserman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
miR-145 is differentially regulated by TGF-ß1 and ischaemia and targets Disabled-2 expression and wnt/ß-catenin activity
Maritza E. Mayorga et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells
Hayato Takahashi et al.
NATURE IMMUNOLOGY (2012)
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
miR-200a Regulates SIRT1 Expression and Epithelial to Mesenchymal Transition (EMT)-like Transformation in Mammary Epithelial Cells
Gabriel Eades et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Downregulation of FIP200 Induces Apoptosis of Glioblastoma Cells and Microvascular Endothelial Cells by Enhancing Pyk2 Activity
Dongyan Wang et al.
PLOS ONE (2011)
Capture of MicroRNA-Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling
Ashish Lal et al.
PLOS GENETICS (2011)
Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
Adel Tabchy et al.
CLINICAL CANCER RESEARCH (2010)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer
Tokuhiro Chano et al.
PLOS ONE (2010)
A Simplified Method for Quantifying Cell Migration/Wound Healing in 96-Well Plates
Patrick Y. K. Yue et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition
Jing Lu et al.
CANCER CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
RB1CC1 activates the promoter and expression of RB1 in human cancer
Kaichiro Ikebuchi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
Raffaele Baffa et al.
JOURNAL OF PATHOLOGY (2009)
Regulation of in situ to invasive breast carcinoma transition
Min Hu et al.
CANCER CELL (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
MicroRNAs as regulators of epithelial-mesenchymal transition
Philip. A. Gregory et al.
CELL CYCLE (2008)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper
Mette Munk Jensen et al.
BMC MEDICAL IMAGING (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression
J Yao et al.
CANCER RESEARCH (2006)
Mechanism of cell cycle regulation by FIP200 in human breast cancer cells
ZK Melkoumian et al.
CANCER RESEARCH (2005)
Myoepithelial cells: Autocrine and paracrine suppressors of breast cancer progression
Sanford H. Barsky et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
In situ analyses of genome instability in breast cancer
K Chin et al.
NATURE GENETICS (2004)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy
K Kerlikowske et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Gene expression profiles of human breast cancer progression
XJ Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
Truncating mutations of RB1CC1 in human breast cancer
T Chano et al.
NATURE GENETICS (2002)
Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis
WJ Zhu et al.
EMBO JOURNAL (2001)
Re: Preclinical and clinical development of cyclin-dependent kinase modulators - Response
AM Senderowicz et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
